Literature DB >> 8039658

The phylogeny of Neospora caninum and Toxoplasma gondii based on ribosomal RNA sequences.

O J Holmdahl1, J G Mattsson, A Uggla, K E Johansson.   

Abstract

Neospora caninum is a newly described cyst-forming coccidium which is the cause of severe neurological disease in dogs. The parasite is morphologically similar to Toxoplasma gondii, but the two species can be differentiated serologically. In order to define the phylogenetic position of N. caninum, we have determined 16S-like rRNA sequences from three members of the family of Sarcocystidae: N. caninum, T. gondii, and Sarcocystis fusiformis. The 16S-like rRNA genes from the three parasites were amplified by polymerase chain reaction and the sequences were determined by direct solid-phase sequencing. The sequences derived were computer aligned with several other 16S-like rRNA sequences from protozoan parasites to construct phylogenetic trees. The study confirmed that N. caninum should be classified as a member of the family Sarcocystidae. However, because of the close relationship to T. gondii it seems questionable that N. caninum should be placed in a new genus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8039658     DOI: 10.1111/j.1574-6968.1994.tb06887.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  16 in total

1.  Toxoplasma gondii rhoptry discharge correlates with activation of the early growth response 2 host cell transcription factor.

Authors:  Eric D Phelps; Kristin R Sweeney; Ira J Blader
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

2.  Identification of bovine Neospora parasites by PCR amplification and specific small-subunit rRNA sequence probe hybridization.

Authors:  M S Ho; B C Barr; A E Marsh; M L Anderson; J D Rowe; A F Tarantal; A G Hendrickx; K Sverlow; J P Dubey; P A Conrad
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

3.  Detection of Neospora from tissues of experimentally infected rhesus macaques by PCR and specific DNA probe hybridization.

Authors:  M S Ho; B C Barr; A F Tarantal; L T Lai; A G Hendrickx; A E Marsh; K W Sverlow; A E Packham; P A Conrad
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

4.  rRNA gene sequence heterogeneity among Toxoplasma gondii strains.

Authors:  K Luton; M Gleeson; A M Johnson
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

5.  Effects of sequence alignment on the phylogeny of Sarcocystis deduced from 18S rDNA sequences.

Authors:  J Ellis; D Morrison
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

6.  Congenital Neospora caninum infection in dairy cattle and associated calfhood mortality.

Authors:  J Paré; M C Thurmond; S K Hietala
Journal:  Can J Vet Res       Date:  1996-04       Impact factor: 1.310

7.  Cloning and characterization of two recombinant Neospora protein fragments and their use in serodiagnosis of bovine neosporosis.

Authors:  K Louie; K W Sverlow; B C Barr; M L Anderson; P A Conrad
Journal:  Clin Diagn Lab Immunol       Date:  1997-11

8.  Molecular characterisation of three regions of the nuclear ribosomal DNA unit and the mitochondrial cox1 gene of Sarcocystis fusiformis from water buffaloes (Bubalus bubalis) in Egypt.

Authors:  Bjørn Gjerde; Mosaad Hilali; Sahar Abdel Mawgood
Journal:  Parasitol Res       Date:  2015-06-09       Impact factor: 2.289

9.  Detection of immunoglobulin G antibodies to Neospora caninum in humans: high seropositivity rates in patients who are infected by human immunodeficiency virus or have neurological disorders.

Authors:  Janaína Lobato; Deise A O Silva; Tiago W P Mineo; Jodi D H F Amaral; Gesmar R Silva Segundo; Julia M Costa-Cruz; Marcelo S Ferreira; Aércio S Borges; José R Mineo
Journal:  Clin Vaccine Immunol       Date:  2006-01

10.  Genetic comparison of Neospora caninum with Toxoplasma and Sarcocystis by random amplified polymorphic DNA-polymerase chain reaction.

Authors:  Z G Guo; A M Johnson
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.